Clever Leaves (CLVR) Competitors

Ampio Pharmaceuticals (NYSE:AMPE) and Clever Leaves (NASDAQ:CLVR) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, earnings, risk, institutional ownership, dividends and valuation.

Which has more volatility and risk, AMPE or CLVR?

Ampio Pharmaceuticals has a beta of 4.69, meaning that its stock price is 369% more volatile than the S&P 500. Comparatively, Clever Leaves has a beta of 3531.01, meaning that its stock price is 353,001% more volatile than the S&P 500.

Which has stronger valuation & earnings, AMPE or CLVR?

Ampio Pharmaceuticals has higher earnings, but lower revenue than Clever Leaves. Ampio Pharmaceuticals is trading at a lower price-to-earnings ratio than Clever Leaves, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ampio Pharmaceuticals	N/A	N/A	-$8.63M	-$11.01	0.00
Clever Leaves	$17.42M	0.00	-$17.90M	-$11.31	0.00

Does the media prefer AMPE or CLVR?

In the previous week, Ampio Pharmaceuticals' average media sentiment score of 0.00 equaled Clever Leaves'average media sentiment score.

Company	Overall Sentiment
Ampio Pharmaceuticals	Neutral
Clever Leaves	Neutral

Do insiders and institutionals have more ownership in AMPE or CLVR?

5.7% of Ampio Pharmaceuticals shares are held by institutional investors. Comparatively, 6.9% of Clever Leaves shares are held by institutional investors. 3.3% of Ampio Pharmaceuticals shares are held by insiders. Comparatively, 8.2% of Clever Leaves shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Is AMPE or CLVR more profitable?

Company	Net Margins	Return on Equity	Return on Assets
Ampio Pharmaceuticals	N/A	N/A	N/A
Clever Leaves	N/A	N/A	N/A

Summary

Clever Leaves beats Ampio Pharmaceuticals on 5 of the 7 factors compared between the two stocks.